Assuntos
Fator VIII/imunologia , Hemofilia A/complicações , Hemofilia A/imunologia , Isoanticorpos/imunologia , Embolia Pulmonar/diagnóstico , Embolia Pulmonar/etiologia , Criança , Pré-Escolar , Fator VIII/uso terapêutico , Hemofilia A/tratamento farmacológico , Humanos , Lactente , Masculino , Tomografia Computadorizada por Raios XRESUMO
Subcutaneous (SQ) vs. intramuscular (IM) vaccination may cause fewer injection site complications in children with bleeding disorders, but little is known about comparative immunogenicity. To compare immunogenicity of hepatitis B virus (HBV) vaccination administered SQ or IM to individuals <2 years old with bleeding disorders, we performed a retrospective analysis of HBV surface antibody titres among patients enrolled in the universal data collection database who had received three doses of HBV vaccine solely by one route (SQ or IM). Data reviewed were from an initial visit before 24 months of age, until time of hepatitis antibody titre testing. The SQ and IM study groups did not differ in demographics, haemophilia type or severity or bleeding history. The mean age at the time of HBV surface antibody (anti-HBs) testing was 56.9 ± 20.3 months. Eighty-five of 92 subjects (92.4%) who received vaccine SQ developed a positive antibody titre (>12 IU/L), compared to 101/114 (88.6%) who received IM (P = 0.30). There was no statistically significant difference in distribution of titre values. The average age of the subjects at time of testing was 53 ± 20 months in the SQ group vs. 60 ± 20 months in the IM group (P = 0.02). The average time between the last dose of vaccine and anti-HBs testing was 47.6 ± 18.5 months among SQ vaccinated subjects vs. 51.6 ± 20.5 months in the IM group (P = 0.2). Immunogenicity to hepatitis B vaccination by the SQ and IM routes is similar.
Assuntos
Transtornos Herdados da Coagulação Sanguínea/imunologia , Transtornos Herdados da Coagulação Sanguínea/virologia , Coleta de Dados , Bases de Dados Factuais , Vacinas contra Hepatite B/administração & dosagem , Vacinas contra Hepatite B/imunologia , Criança , Pré-Escolar , Feminino , Anticorpos Anti-Hepatite B/imunologia , Vacinas contra Hepatite B/efeitos adversos , Humanos , Lactente , Injeções Intramusculares , Injeções Subcutâneas , Masculino , Estudos Retrospectivos , VacinaçãoRESUMO
The plant Arabidopsis thaliana (Arabidopsis) has become an important model species for the study of many aspects of plant biology. The relatively small size of the nuclear genome and the availability of extensive physical maps of the five chromosomes provide a feasible basis for initiating sequencing of the five chromosomes. The YAC (yeast artificial chromosome)-based physical map of chromosome 4 was used to construct a sequence-ready map of cosmid and BAC (bacterial artificial chromosome) clones covering a 1.9-megabase (Mb) contiguous region, and the sequence of this region is reported here. Analysis of the sequence revealed an average gene density of one gene every 4.8 kilobases (kb), and 54% of the predicted genes had significant similarity to known genes. Other interesting features were found, such as the sequence of a disease-resistance gene locus, the distribution of retroelements, the frequent occurrence of clustered gene families, and the sequence of several classes of genes not previously encountered in plants.